rs148975763

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000489.6(ATRX):​c.4635C>A​(p.Thr1545Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000605 in 1,206,259 control chromosomes in the GnomAD database, including 5 homozygotes. There are 195 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0033 ( 1 hom., 103 hem., cov: 22)
Exomes 𝑓: 0.00033 ( 4 hom. 92 hem. )

Consequence

ATRX
NM_000489.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.213

Publications

2 publications found
Variant links:
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
ATRX Gene-Disease associations (from GenCC):
  • alpha thalassemia-X-linked intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • ATR-X-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability-hypotonic facies syndrome, X-linked, 1
    Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant X-77635979-G-T is Benign according to our data. Variant chrX-77635979-G-T is described in ClinVar as Benign. ClinVar VariationId is 93138.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.213 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00328 (368/112202) while in subpopulation AFR AF = 0.0114 (351/30909). AF 95% confidence interval is 0.0104. There are 1 homozygotes in GnomAd4. There are 103 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 103 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000489.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATRX
NM_000489.6
MANE Select
c.4635C>Ap.Thr1545Thr
synonymous
Exon 16 of 35NP_000480.3
ATRX
NM_138270.5
c.4521C>Ap.Thr1507Thr
synonymous
Exon 15 of 34NP_612114.2P46100-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATRX
ENST00000373344.11
TSL:1 MANE Select
c.4635C>Ap.Thr1545Thr
synonymous
Exon 16 of 35ENSP00000362441.4P46100-1
ATRX
ENST00000395603.7
TSL:1
c.4521C>Ap.Thr1507Thr
synonymous
Exon 15 of 34ENSP00000378967.3P46100-4
ATRX
ENST00000480283.5
TSL:1
n.*4263C>A
non_coding_transcript_exon
Exon 17 of 36ENSP00000480196.1A0A087WWG0

Frequencies

GnomAD3 genomes
AF:
0.00328
AC:
368
AN:
112148
Hom.:
1
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0114
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000846
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000368
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000752
Gnomad OTH
AF:
0.00198
GnomAD2 exomes
AF:
0.000919
AC:
167
AN:
181704
AF XY:
0.000588
show subpopulations
Gnomad AFR exome
AF:
0.0116
Gnomad AMR exome
AF:
0.000549
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.000223
GnomAD4 exome
AF:
0.000331
AC:
362
AN:
1094057
Hom.:
4
Cov.:
29
AF XY:
0.000256
AC XY:
92
AN XY:
359723
show subpopulations
African (AFR)
AF:
0.0118
AC:
311
AN:
26307
American (AMR)
AF:
0.000540
AC:
19
AN:
35166
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19320
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30179
South Asian (SAS)
AF:
0.0000186
AC:
1
AN:
53890
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40505
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3860
European-Non Finnish (NFE)
AF:
0.00000358
AC:
3
AN:
838889
Other (OTH)
AF:
0.000609
AC:
28
AN:
45941
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00328
AC:
368
AN:
112202
Hom.:
1
Cov.:
22
AF XY:
0.00300
AC XY:
103
AN XY:
34388
show subpopulations
African (AFR)
AF:
0.0114
AC:
351
AN:
30909
American (AMR)
AF:
0.000845
AC:
9
AN:
10651
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3585
South Asian (SAS)
AF:
0.000369
AC:
1
AN:
2708
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6058
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.0000752
AC:
4
AN:
53203
Other (OTH)
AF:
0.00195
AC:
3
AN:
1536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00174
Hom.:
6
Bravo
AF:
0.00391

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Alpha thalassemia-X-linked intellectual disability syndrome (2)
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
3.4
DANN
Benign
0.66
PhyloP100
0.21
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148975763; hg19: chrX-76891470; API